SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination

The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction

Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,216 · see citing works

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676 · see citing works

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · see citing works

SUMO

Hay, R. T. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.012 · Cited by 1,623 · see citing works

Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study

Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588 · see citing works

SUMO-1 Modification of IκBα Inhibits NF-κB Activation

Desterro, J. M. P., Rodríguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,048 · see citing works

Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules

Alonso, A. D. C., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0796-783 · Cited by 859 · see citing works

Ubiquitin Is a Component of Paired Helical Filaments in Alzheimer's Disease

Mori, H., Kondo, J., & Ihara, Y. (1987) · Science · doi:10.1126/science.3029875 · Cited by 843 · see citing works

Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease.

Köpke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., & Grundke-Iqbal, I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80536-5 · Cited by 779 · see citing works

Alzheimer's Disease: A Central Role for Amyloid

Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 752 · see citing works

Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738 · see citing works

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 735 · cited 1× · see citing works

DEFECTIVE BRAIN MICROTUBULE ASSEMBLY IN ALZHEIMER'S DISEASE

Iqbal, K., Zaidi, T., Wen, G. Y., Grundke, I., MERZ, P. A., Shaikh, S., Wisniewski, H., Alafuzoff, I. I., & Winblad, B. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92134-3 · Cited by 727 · see citing works

The acetylation of tau inhibits its function and promotes pathological tau aggregation

Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Nature Communications · doi:10.1038/ncomms1255 · Cited by 724 · see citing works

Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease

Gong, C., & Iqbal, K. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785909111 · Cited by 649 · see citing works

Post-translational modifications of tau protein: Implications for Alzheimer's disease

Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 645 · see citing works

Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.

Perry, G., Friedman, R., Shaw, G., & Chau, V (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3033 · Cited by 623 · see citing works

β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

Koh, J., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617 · see citing works

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

Wang, J., Grundke, I., & Iqbal, K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05226.x · Cited by 553 · see citing works

Phosphorylation of Microtubule-associated Protein Tau Is Regulated by Protein Phosphatase 2A in Mammalian Brain

Gong, C.-X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I., & Iqbal, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5535 · Cited by 405 · see citing works

GSK-3 is essential in the pathogenesis of Alzheimer's disease

Takashima, A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s335 · Cited by 395 · see citing works

Microtubule-associated protein tau in development, degeneration and protection of neurons

Wang, J., & Liu, F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.002 · Cited by 395 · see citing works

Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate

Fukuda, I., Ito, A., Hirai, G., Nishimura, S., Kawasaki, H., Saitoh, H., Kimura, K.-I., Sodeoka, M., & Yoshida, M. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.01.009 · Cited by 355 · see citing works

The Endosomal-Lysosomal System of Neurons in Alzheimer's Disease Pathogenesis: A Review

Nixon, R., Cataldo, A., & Mathews, P. (2000) · Neurochemical Research · doi:10.1023/a:1007675508413 · Cited by 332 · see citing works

Ubiquitin and its kin: how close are the family ties?

Jentsch, S., & Pyrowolakis, G. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01785-2 · Cited by 322 · see citing works

Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-Synuclein

Dorval, V., & Fraser, P. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510127200 · Cited by 319 · see citing works

Granular Tau Oligomers as Intermediates of Tau Filaments

Maeda, S., Sahara, N., Saito, Y., Murayama, M., Yoshiike, Y., Kim, H., Miyasaka, T., Murayama, S., Ikai, A., & Takashima, A. (2007) · Biochemistry · doi:10.1021/bi061359o · Cited by 309 · see citing works

Immunochemical analysis of the turnover of ubiquitin-protein conjugates in intact cells. Relationship to the breakdown of abnormal proteins.

Hershko, A., Eytan, E., Ciechanover, A. J., & Haas, A. L. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45327-1 · Cited by 290 · see citing works

Microtubule-Associated Protein Tau

Yen, S.-H. C., Nacharaju, P., Ko, L., Kenessey, Á., & Liu, W.-K. (1998) · Elsevier eBooks · doi:10.1016/b978-012734610-6/50012-9 · Cited by 284 · see citing works

Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression

Hamano, T., Gendron, T. F., Causevic, E., Yen, S., Lin, W., Isidoro, C., DeTure, M., & Ko, L. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06084.x · Cited by 283 · see citing works

SUMO protein modification

Dohmen, R. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.021 · Cited by 270 · see citing works

Small Ubiquitin-like Modifier (SUMO) Recognition of a SUMO Binding Motif

Song, J., Zhang, Z., Hu, W., & Chen, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507059200 · Cited by 264 · see citing works

Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention

Iqbal, K., & Grundke, I. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00225.x · Cited by 238 · see citing works

Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments

Zhu, L.-Q., Wang, S.-H., Liu, D., Yin, Y.-Y., Tian, Q., Wang, X.-C., Wang, Q., Chen, J.-G., & Wang, J.-Z. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3321-07.2007 · Cited by 234 · see citing works

Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest

Ulrich, H. D. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.08.002 · Cited by 198 · see citing works

SUMO on the road to neurodegeneration

Dorval, V., & Fraser, P. E. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.017 · Cited by 182 · see citing works

A Caspase Cleaved Form of Tau Is Preferentially Degraded through the Autophagy Pathway

Dolan, P. J., & Johnson, G. V. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.110940 · Cited by 147 · see citing works

GSK-3β Is Required for Memory Reconsolidation in Adult Brain

Kimura, T., Yamashita, S., Nakao, S., Park, J.-M., Murayama, M., Mizoroki, T., Yoshiike, Y., Sahara, N., & Takashima, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003540 · Cited by 136 · see citing works

Tau Phosphorylation, Tangles, and Neurodegeneration

Geschwind, D. H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00681-0 · Cited by 129 · see citing works

Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments

Grundke, I., VORBRODT, A. W., Iqbal, K., Tung, Y. C., Wang, G. P., & Wisniewski, H. M. (1988) · Molecular Brain Research · doi:10.1016/0169-328x(88)90017-4 · Cited by 128 · see citing works

Phosphoprotein Phosphatase 2A: A Novel Druggable Target for Alzheimer’s Disease

Voronkov, M. V., Braithwaite, S. P., & Stock, J. B. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.47 · Cited by 121 · see citing works

Cytosolic Proteolysis of τ by Cathepsin D in Hippocampus Following Suppression of Cathepsins B and L

Bednarski, E., & LYNCH, G. S. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67051846.x · Cited by 110 · see citing works

Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease

Iqbal, K., & Grundke, I. (1991) · Molecular Neurobiology · doi:10.1007/bf02935561 · Cited by 108 · see citing works

SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease

Pountney, D. L., Huang, Y. M., Burns, R. J., Haan, E., Thompson, P. D., Blumbergs, P. C., & Gai, W. P. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.07.004 · Cited by 107 · see citing works

Alzheimer neurofibrillary tangles: Monoclonal antibodies to inherent antigen(s)

Wang, G. P., Grundke, I., Kascsak, R., Iqbal, K., & Wisniewski, H. M. (1984) · Acta Neuropathologica · doi:10.1007/bf00687608 · Cited by 104 · see citing works

Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss

Kimura, T., Fukuda, T., Sahara, N., Yamashita, S., Murayama, M., Mizoroki, T., Yoshiike, Y., Lee, B., Sotiropoulos, I., Maeda, S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.136630 · Cited by 97 · see citing works

Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions

Grune, T., Botzen, D., Engels, M., Voß, P., Kaiser, B., Jung, T., Grimm, S., Ermak, G., & Davies, K. J. A. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.008 · Cited by 85 · see citing works

Cytosolic Abnormally Hyperphosphorylated Tau But Not Paired Helical Filaments Sequester Normal MAPs and Inhibit Microtubule Assembly

Iqbal, K., Alonso, A. D. C., & Grundke, I. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14402 · Cited by 77 · see citing works

SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice

Takahashi, K., Ishida, M., Komano, H., & Takahashi, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.012 · Cited by 75 · see citing works

Potential Compensatory Responses Through Autophagic/Lysosomal Pathways in Neurodegenerative Diseases

Butler, D., Nixon, R. A., & Bahr, B. A. (2006) · Autophagy · doi:10.4161/auto.2729 · Cited by 56 · see citing works

Dehydroevodiamine attenuates tau hyperphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats

Peng, J.-H., Zhang, C.-E., Wei, W., Hong, X., Pan, X., & Wang, J. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.008 · Cited by 41 · see citing works

Genetic Evidence That Polysumoylation Bypasses the Need for a SUMO-Targeted Ub Ligase

Mullen, J. R., Das, M. M., & Brill, S. J. (2010) · Genetics · doi:10.1534/genetics.110.124347 · Cited by 31 · see citing works

Regulation of Glycogen Synthase Kinase 3β Functions by Modification of the Small Ubiquitin-Like Modifier

Lee, E. J., Hyun, S. H., Chun, J., Shin, S. H., Yeon, K. H., Kwak, M. K., Park, T. Y., & Kang, S. S. (2008) · The Open Biochemistry Journal · doi:10.2174/1874091x00802010067 · Cited by 26 · see citing works

Neuronal death and GSK-3β: a tau fetish?

Mattson, M. P. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01838-5 · Cited by 22 · see citing works

Fighting Bax: towards a Parkinson's disease therapy

Ploix, C. C., & Spier, A. D. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01837-3 · Cited by 5 · see citing works

Tau in physiology and pathology

Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251 · see citing works

Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.

Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138 · see citing works

Roles of tau protein in health and disease

Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003 · see citing works

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works

Control of protein stability by post-translational modifications

Lee, J. M., Hammarén, H. M., Savitski, M. M., & Baek, S. H. (2023) · Nature Communications · doi:10.1038/s41467-023-35795-8 · Cited by 822 · see citing works

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

Rawat, P., Sehar, U., Bisht, J., Selman, A., Culberson, J., & Reddy, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112841 · Cited by 509 · see citing works

Current understanding of metal ions in the pathogenesis of Alzheimer’s disease

Wang, L., Yin, Y.-L., Liu, X.-Z., Shen, P., Zheng, Y.-G., Lan, X.-R., Lu, C.-B., & Wang, J.-Z. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00189-z · Cited by 454 · see citing works

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442 · see citing works

Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy

Zheng, Q., & Wang, X. (2024) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 454 · see citing works

Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains

Arakhamia, T., Lee, C. E., Carlomagno, Y., Kumar, M., Duong, D. M., Wesseling, H., Kundinger, S. R., Wang, K., Williams, D., Deture, M. A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.027 · Cited by 400 · see citing works

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Neddens, J., Temmel, M., Flunkert, S., Kerschbaumer, B., Hoeller, C., Loeffler, T., Niederkofler, V., Daum, G., Attems, J., & Hutter-Paier, B. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0557-6 · Cited by 384 · see citing works

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation

Alquezar, C., Arya, S., & Kao, A. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.595532 · Cited by 367 · see citing works

A walk through tau therapeutic strategies

Jadhav, S., Ávila, J., Schöll, M., Kovács, G. G., Kövari, E., Škrabana, R., Evans, L., Kontseková, E., Malawska, B., de Silva, R., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0664-z · Cited by 286 · see citing works

Tau Proteins and Tauopathies in Alzheimer’s Disease

Chong, F. P., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0574-1 · Cited by 248 · see citing works

Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts

Celen, A. B., & Şahin, U. (2020) · FEBS Journal · doi:10.1111/febs.15319 · Cited by 247 · see citing works

Protein SUMOylation modification and its associations with disease

Yang, Y., He, Y., Wang, X., liang, Z., He, G., Zhang, P., Zhu, H., Xu, N., & Liang, S. (2017) · Open Biology · doi:10.1098/rsob.170167 · Cited by 216 · see citing works

MAPT/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration

Feng, Q., Luo, Y., Zhang, X., Yang, X., Hong, X.-Y., Sun, D., Li, X., Hu, Y., Li, X., Zhang, J., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1633862 · Cited by 211 · see citing works

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

Liu, E., Zhang, Y., & Wang, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 220 · see citing works

It’s all about tau

Tapia‐Rojas, C., Cabezas-Opazo, F., Deaton, C. A., Vergara, E. H., Johnson, G. V. W., & Quintanilla, R. A. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.005 · Cited by 195 · see citing works

SUMOylation and ubiquitination reciprocally regulate α-synuclein degradation and pathological aggregation

Rott, R., Szargel, R., Shani, V., Hamza, H., Savyon, M., Elghani, F. A., Bandopadhyay, R., & Engelender, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704351114 · Cited by 189 · see citing works

Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV/CREB signaling

Yin, Y., Gao, D., Wang, Y., Wang, Z.-H., Wang, X., Ye, J., Wu, D., Fang, L., Pi, G., Yang, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604519113 · Cited by 174 · see citing works

Modifications and Trafficking of APP in the Pathogenesis of Alzheimer’s Disease

Wang, X., Zhou, X., Li, G., Zhang, Y., Wu, Y., & Song, W. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00294 · Cited by 173 · see citing works

Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review

Schaffert, L.-N., & Carter, W. G. (2020) · Brain Sciences · doi:10.3390/brainsci10040232 · Cited by 165 · see citing works

Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies

Limorenko, G., & Lashuel, H. A. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00127b · Cited by 162 · see citing works

Amyloidogenesis of Tau protein

Niżyński, B., Dzwolak, W., & Nieznański, K. (2017) · Protein Science · doi:10.1002/pro.3275 · Cited by 157 · see citing works

Discovering the landscape of protein modifications

Keenan, E. K., Zachman, D. K., & Hirschey, M. D. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.015 · Cited by 154 · see citing works

Palmitoylation in Alzheimers disease and other neurodegenerative diseases

Cho, E., & Park, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.008 · Cited by 142 · see citing works

Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies

Kontaxi, C., Piccardo, P., & Gill, A. C. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00056 · Cited by 138 · see citing works

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease

Zhou, Y., Shi, J., Chu, D., Hu, W. H., Guan, Z., Gong, C., Iqbal, K., & Liu, F. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00027 · Cited by 123 · see citing works

Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo

Wang, P., Joberty, G., Buist, A., Vanoosthuyse, A., Stancu, I., Vasconcelos, B., Pierrot, N., Faelth-Savitski, M., Kienlen‐Campard, P., Octave, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1663-9 · Cited by 118 · see citing works

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Balmik, A. A., & Chinnathambi, S. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00732-z · Cited by 108 · see citing works

Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis

Li, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103 · see citing works

Pathological Changes of Tau Related to Alzheimer’s Disease

Chu, D., & Liu, F. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00457 · Cited by 103 · see citing works

Ubiquitin-dependent and independent roles of SUMO in proteostasis

Liebelt, F., & Vertegaal, A. C. O. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00091.2016 · Cited by 99 · see citing works

Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies

Zhang, X., Wang, J., Zhang, Z., & Ye, K. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00429-6 · Cited by 106 · see citing works

Asperterpenes A and B, two unprecedented meroterpenoids from Aspergillus terreus with BACE1 inhibitory activities

Qi, C., Bao, J., Wang, J., Zhu, H., Xue, Y., Wang, X., Li, H., Sun, W., Gao, W., Lai, Y., et al. (2016) · Chemical Science · doi:10.1039/c6sc02464e · Cited by 95 · see citing works

A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy

Hernández, I., Luna, G., Rauch, J. N., Reis, S. A., Giroux, M., Karch, C. M. M., Boctor, D., Sibih, Y., Storm, N. J., Díaz, A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat3005 · Cited by 95 · see citing works

Sumoylation in Physiology, Pathology and Therapy

Şahin, U., de Thé, H., & Lallemand-Breitenbach, V. (2022) · Cells · doi:10.3390/cells11050814 · Cited by 92 · see citing works

Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance

Wang, L., Bharti, Kumar, R., Pavlov, P. F., & Winblad, B. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112915 · Cited by 92 · see citing works

Liquid–liquid phase separation of Tau by self and complex coacervation

Najafi, S., Lin, Y., Longhini, A. P., Zhang, X., Delaney, K. T., Kosik, K. S., Fredrickson, G. H., Shea, J., & Han, S. (2021) · Protein Science · doi:10.1002/pro.4101 · Cited by 87 · see citing works

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders

Manzanza, N. D. O., Sedlackova, L., & Kalaria, R. N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690293 · Cited by 89 · see citing works

A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies

Zheng, J., Tian, N., Liu, F., Zhang, Y., Su, J., Gao, Y., Deng, M., Wei, L., Ye, J., Li, H., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00669-2 · Cited by 78 · see citing works

Extranuclear SUMOylation in Neurons

Henley, J. M., Carmichael, R. E., & Wilkinson, K. A. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.02.004 · Cited by 77 · see citing works

Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome

Ma, L., Herren, A. W., Espinal, G. M., Randol, J. L., McLaughlin, B. E., Martínez‐Cerdeño, V., Pessah, I. N., Hagerman, R. J., & Hagerman, P. J. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0796-1 · Cited by 76 · see citing works

Autophagic Pathways to Clear the Tau Aggregates in Alzheimer’s Disease

Gorantla, N. V., & Chinnathambi, S. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00897-0 · Cited by 75 · see citing works

Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration

Boyarko, B., & HOOK, V. Y. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.702788 · Cited by 74 · see citing works

The Role of Post-Translational Modifications on the Structure and Function of Tau Protein

Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02002-0 · Cited by 74 · see citing works

The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer’s Disease

Guha, S. K., Johnson, G. V. W., & Nehrke, K. W. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02084-0 · Cited by 72 · see citing works

Role of Post‐translational Modifications in Alzheimer's Disease

Ramesh, M., Gopinath, P., & Govindaraju, T. (2019) · ChemBioChem · doi:10.1002/cbic.201900573 · Cited by 68 · see citing works

Sumoylation in Synaptic Function and Dysfunction

Schorova, L., & Martin, S. (2016) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2016.00009 · Cited by 68 · see citing works

Role of microtubule-associated protein tau phosphorylation in Alzheimer’s disease

Ma, R.-H., Zhang, Y., Hong, X.-Y., Zhang, J., Wang, J., & Liu, G. (2017) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-017-1732-x · Cited by 66 · see citing works

Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy

Ye, J., Wan, H., Chen, S., & Liu, G. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385847 · Cited by 69 · see citing works

SUMOylation in Neurodegenerative Diseases

Princz, A., & Tavernarakis, N. (2019) · Gerontology · doi:10.1159/000502142 · Cited by 62 · see citing works

Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases

Hwang, J., Lee, A., & Kho, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095053 · Cited by 62 · see citing works

Tau, microtubule dynamics, and axonal transport: New paradigms for neurodegenerative disease

Cario, A., & Berger, C. L. (2023) · BioEssays · doi:10.1002/bies.202200138 · Cited by 63 · see citing works

Sumoylation: Implications for Neurodegenerative Diseases

Anderson, D. B., Zanella, C. A., Henley, J. M., & Cimarosti, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_16 · Cited by 61 · see citing works

Role of SUMOylation in Neurodegenerative Diseases

Mandel, N., & Agarwal, N. (2022) · Cells · doi:10.3390/cells11213395 · Cited by 59 · see citing works

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Wu, J., Wu, J., Chen, T., Cai, J., & Ren, R. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105880 · Cited by 61 · see citing works

Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis

Liu, Q., Wang, X., Hu, Y., Zhao, J.-N., Huang, C.-H., Li, T., Zhang, B.-G., He, Y., Wu, Y.-Q., Zhang, Z.-J., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102697 · Cited by 58 · see citing works

Posttranslational Modifications of α-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases

Hassanzadeh, K., Liu, J., Maddila, S. C., & Mouradian, M. M. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001111 · Cited by 53 · see citing works

BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer’s disease

Bao, J., Qin, M., Mahaman, Y. A. R., Zhang, B., Huang, F., Zeng, K., Xia, Y., Ke, D., Wang, Q., Liu, R., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800498115 · Cited by 50 · see citing works

Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network

Sonawane, S. K., & Chinnathambi, S. (2021) · Oncotarget · doi:10.18632/oncotarget.27963 · Cited by 51 · see citing works

SUMOylation-Mediated Response to Mitochondrial Stress

He, J., Cheng, J., & Wang, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165657 · Cited by 51 · see citing works

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies

Fuster-Matanzo, A., Hernández, F., & Ávila, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030645 · Cited by 48 · see citing works

SUMO paralogue–specific functions revealed through systematic analysis of human knockout cell lines and gene expression data

Bouchard, D., Wang, W., Yang, W.-C., He, S., Garcia, A., & Matunis, M. J. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e21-01-0031 · Cited by 47 · see citing works

Nature of Tau-Associated Neurodegeneration and the Molecular Mechanisms

Yang, Y., & Wang, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170788 · Cited by 46 · see citing works

Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases

Wang, W., & Matunis, M. J. (2023) · Cells · doi:10.3390/cells13010008 · Cited by 45 · see citing works

Cytoskeletal Proteins and Alzheimer’s Disease Pathogenesis: Focusing on the Interplay with Tau Pathology

Jiang, G., Xie, G., Li, X., & Xiong, J. (2025) · Biomolecules · doi:10.3390/biom15060831 · Cited by 45 · see citing works

Sex Differences in the Cognitive and Hippocampal Effects of Streptozotocin in an Animal Model of Sporadic AD

Bao, J., Mahaman, Y. A. R., Liu, R., Wang, J., Zhang, Z., Zhang, B., & Wang, X. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00347 · Cited by 45 · see citing works

A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function

Dustrude, E. T., Perez‐Miller, S., François‐Moutal, L., Moutal, A., Khanna, M., & Khanna, R. (2017) · Channels · doi:10.1080/19336950.2017.1299838 · Cited by 44 · see citing works

Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders

Loh, D., & Reiter, R. J. (2021) · Antioxidants · doi:10.3390/antiox10091483 · Cited by 43 · see citing works

Experimental Evidence of the Benefits of Acupuncture for Alzheimer's Disease: An Updated Review

Yu, C.-C., Du, Y., Wang, S., Liu, L.-B., Shen, F., Wang, L., Lin, Y.-F., & Kong, L.-H. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.549772 · Cited by 42 · see citing works

To target Tau pathologies, we must embrace and reconstruct their complexities

Limorenko, G., & Lashuel, H. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105536 · Cited by 39 · see citing works

USP10 deubiquitinates Tau, mediating its aggregation

Wei, Z. C., Zeng, K., Hu, J., Li, X., Huang, F., Zhang, B., Wang, J., Liu, R., Li, H., & Wang, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05170-4 · Cited by 40 · see citing works

ASC-J9 ® suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3

Lin, W.-Y., Luo, J., Sun, Y., Lin, C.-Y., Li, G., Niu, Y., & Chang, C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.007 · Cited by 40 · see citing works

Signaling pathways and posttranslational modifications of tau in Alzheimer's disease: the humanization of yeast cells

Heinisch, J. J., & Brandt, R. (2016) · Microbial Cell · doi:10.15698/mic2016.04.489 · Cited by 39 · see citing works

SUMOylation Prevents Huntingtin Fibrillization and Localization onto Lipid Membranes

Sedighi, F., Adegbuyiro, A., & Legleiter, J. A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00509 · Cited by 40 · see citing works

SUMOylation in α-Synuclein Homeostasis and Pathology

Savyon, M., & Engelender, S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00167 · Cited by 39 · see citing works

The function of SUMOylation and its crucial roles in the development of neurological diseases

Chen, X., Zhang, Y., Wang, Q., Qin, Y., Yang, X., Xing, Z., Shen, Y., Wu, H., & Qi, Y. (2021) · The FASEB Journal · doi:10.1096/fj.202002702r · Cited by 39 · see citing works

The propagation mechanisms of extracellular tau in Alzheimer’s disease

Wei, Y., Liu, M., & Wang, D. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10573-y · Cited by 39 · see citing works

SUMO1 impact on Alzheimer disease pathology in an amyloid-depositing mouse model

Knock, E., Matsuzaki, S., Takamura, H., Satoh, K., Rooke, G., Han, K., Zhang, H., Staniszewski, A., Katayama, T., Arancio, O., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.11.015 · Cited by 37 · see citing works

Drp1 SUMO/deSUMOylation by Senp5 isoforms influences ER tubulation and mitochondrial dynamics to regulate brain development

Yamada, S., Sato, A., Ishihara, N., Akiyama, H., & Sakakibara, S. (2021) · iScience · doi:10.1016/j.isci.2021.103484 · Cited by 37 · see citing works

Sequential posttranslational modifications regulate PKC degradation

Wang, Y., Wang, Y., Zhang, H., Gao, Y., Huang, C., Zhou, A., Zhou, Y., & Li, Y. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-09-0624 · Cited by 36 · see citing works

SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation

Wu, R., Fang, J., Liu, M., Jun, A., Liu, J., Chen, W., Li, J., Ma, G., Zhang, Z., Zhang, B., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012338 · Cited by 36 · see citing works

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

Gu, J., & Liu, F. (2020) · Current Medical Science · doi:10.1007/s11596-020-2282-1 · Cited by 38 · see citing works

RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling

Dai, F., Qi, Y., Guan, W., Meng, G., Liu, Z., Zhang, T., & Yao, W. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.07.010 · Cited by 35 · see citing works

Activating transcription factor 3 SUMOylation is involved in angiotensin II-induced endothelial cell inflammation and dysfunction

Zhang, Z.-B., Ruan, C., Chen, D.-R., Zhang, K., Chen, Y., & Gao, P. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.02.001 · Cited by 34 · see citing works

Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease

Carroll, T., Guha, S. K., Nehrke, K. W., & Johnson, G. V. W. (2021) · Biology · doi:10.3390/biology10101047 · Cited by 35 · see citing works

Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies

Ávila, J., Pallas‐Bazarra, N., Bolós, M., Sayas, C. L., & Hernández, F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1131269 · Cited by 34 · see citing works

Genetic Analyses of Alzheimer’s Disease in China: Achievements and Perspectives

Zhang, D., Xu, M., Bi, R., & Yao, Y. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00435 · Cited by 32 · see citing works

PDPK1 regulates autophagosome biogenesis by binding to PIK3C3

Hu, B., Zhang, Y., Deng, T., Gu, J., Liu, J., Yang, H. M., Xu, Y., Yan, Y., Yang, F., Zhang, H., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1817279 · Cited by 32 · see citing works

Role of Polyphenols on Gut Microbiota and the Ubiquitin-Proteasome System in Neurodegenerative Diseases

Nargeh, H., Aliabadi, F., Ajami, M., & Pazoki–Toroudi, H. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00923 · Cited by 31 · see citing works

SUMOylation as a Therapeutic Target for Myocardial Infarction

Zhao, W., Zhang, X., & Rong, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.701583 · Cited by 32 · see citing works

Peripheral Mitochondrial Dysfunction: A Potential Contributor to the Development of Metabolic Disorders and Alzheimer’s Disease

Sultana, M. A., Hia, R. A., Akinsiku, O., & Hegde, V. K. (2023) · Biology · doi:10.3390/biology12071019 · Cited by 31 · see citing works

Battling Alzheimer’s Disease: Targeting SUMOylation-Mediated Pathways

Martins, W. C., Tasca, C. I., & Cimarosti, H. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1681-3 · Cited by 32 · see citing works

SUMOylation, aging and autophagy in neurodegeneration

Vijayakumaran, S., & Pountney, D. L. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.02.015 · Cited by 32 · see citing works

Free d-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking d-aspartate oxidase activity

Nuzzo, T., Feligioni, M., Cristino, L., Pagano, I., Marcelli, S., Iannuzzi, F., Imperatore, R., D’Angelo, L., Petrella, C., Carella, M., et al. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.02.014 · Cited by 32 · see citing works

Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies

Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32 · see citing works

Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology

Kalyaanamoorthy, S., Opare, S. K. A., Xu, X., Ganesan, A., & Rao, P. P. N. (2024) · Current Alzheimer Research · doi:10.2174/0115672050301407240408033046 · Cited by 31 · see citing works

Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer’s disease and related tauopathies

Su, J., Xiao, Y., Wei, L., Lei, H., Sun, F., Wang, W., Yin, J., Xiong, R., Li, S., Zhang, P., et al. (2024) · 中国科学通报：英文版 · doi:10.1016/j.scib.2024.01.019 · Cited by 29 · see citing works

SUMO inhibits Tau aggregation in Alzheimer’s disease

Chinnathambi, S., & Rangappa, N. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.02.001 · Cited by 3 · see citing works

P3–311: Sumo modification of natively unfolded proteins tau and alpha–synuclein

Dorval, V., & Fraser, P. E. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1581

SUMO2 Protects Against Tau-induced Synaptic and Cognitive DysfunctionPreprint

Orsini, F., Argyrousi, E. K., Restelli, E., Ford, L. K., Takamura, H., Matsuzaki, S., Zentilin, L., Pascente, R., Kanaan, N. M., Soni, R. K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.11.516192 · Cited by 5 · see citing works

Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-Synuclein

Dorval, V., & Fraser, P. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510127200 · Cited by 319 · see citing works

Facilitation of SUMO (small ubiquitin‐like modifier) modification at tau 340‐lys residue (a microtubule‐associated protein) through phosphorylation at 214‐ser residue

Lee, E. J., Hyun, S. H., Chun, J., Ahn, H. R., & Kang, S. S. (2007) · Integrative Biosciences · doi:10.1080/17386357.2007.9647314 · Cited by 2 · see citing works